Cumberland Pharmaceuticals (CPIX)
1.57
0.00 (0.00%)
Upcoming Events
Latest Headlines
NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS
April 2, 2024 4:05 PM - PR NewsWire
Form 4 CUMBERLAND PHARMACEUTICA For: Mar 25 Filed by: Krogulski Kenneth
March 26, 2024 8:34 PM - SEC Filing
Form 4 CUMBERLAND PHARMACEUTICA For: Mar 25 Filed by: Jones James
March 26, 2024 8:33 PM - SEC Filing
Form 4 CUMBERLAND PHARMACEUTICA For: Mar 25 Filed by: Galante Joseph C
March 26, 2024 8:32 PM - SEC Filing
Form 4 CUMBERLAND PHARMACEUTICA For: Mar 25 Filed by: Young Caroline
March 26, 2024 8:32 PM - SEC Filing
Form 4 CUMBERLAND PHARMACEUTICA For: Mar 25 Filed by: Brown Martin S JR
March 26, 2024 8:30 PM - SEC Filing
Form 4 CUMBERLAND PHARMACEUTICA For: Mar 23 Filed by: KAZIMI A J
March 26, 2024 8:29 PM - SEC Filing
Form 4 CUMBERLAND PHARMACEUTICA For: Mar 23 Filed by: Herman James L
March 26, 2024 8:26 PM - SEC Filing
Form 4 CUMBERLAND PHARMACEUTICA For: Mar 23 Filed by: Bitterman Chris T.
March 26, 2024 8:25 PM - SEC Filing
Form 4 CUMBERLAND PHARMACEUTICA For: Mar 23 Filed by: Anthony Todd M.
March 26, 2024 8:24 PM - SEC Filing
Form 4 CUMBERLAND PHARMACEUTICA For: Mar 23 Filed by: Hamm John M.
March 26, 2024 8:23 PM - SEC Filing
Form ARS CUMBERLAND PHARMACEUTICA For: Dec 31
March 22, 2024 4:08 PM - SEC Filing
Form 8-K CUMBERLAND PHARMACEUTICA For: Mar 20
March 20, 2024 5:21 PM - SEC Filing
Form 424B5 CUMBERLAND PHARMACEUTICA
March 20, 2024 5:16 PM - SEC Filing
Form DEFA14A CUMBERLAND PHARMACEUTICA
March 13, 2024 5:05 PM - SEC Filing
Form DEF 14A CUMBERLAND PHARMACEUTICA For: Dec 31
March 13, 2024 5:04 PM - SEC Filing
Form 10-K CUMBERLAND PHARMACEUTICA For: Dec 31
March 13, 2024 6:03 AM - SEC Filing
Form 8-K CUMBERLAND PHARMACEUTICA For: Mar 05
March 5, 2024 5:10 PM - SEC Filing
Cumberland Pharmaceuticals (CPIX) Reports Q4 EPS of $0.17
March 5, 2024 4:27 PM - StreetInsider
Cumberland Pharmaceuticals Reports Annual 2023 Financial Results
March 5, 2024 4:05 PM - PR NewsWire
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL RESULTS
February 27, 2024 4:05 PM - PR NewsWire
Form SC 13G CUMBERLAND PHARMACEUTICA Filed by: CUMBERLAND PHARMACEUTICALS INC
February 9, 2024 5:28 PM - SEC Filing
Full Article List
